Inhibiting Angiogenesis in Breast Cancer: The Beginning of the End or the End of the Beginning?

被引:26
作者
Rugo, Hope S. [1 ]
机构
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
关键词
PHASE-III; NEOADJUVANT CHEMOTHERAPY; TUMOR ANGIOGENESIS; 1ST-LINE TREATMENT; OPEN-LABEL; BEVACIZUMAB; SUNITINIB; METASTASIS; PACLITAXEL; TRIAL;
D O I
10.1200/JCO.2011.38.5492
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:898 / 901
页数:5
相关论文
共 25 条
[1]  
An SJ, MED ONCOL
[2]  
[Anonymous], J CLIN ONCOL S
[3]  
[Anonymous], J CLIN ONCOL S15
[4]   Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer [J].
Barrios, Carlos H. ;
Liu, Mei-Ching ;
Lee, Soo Chin ;
Vanlemmens, Laurence ;
Ferrero, Jean-Marc ;
Tabei, Toshio ;
Pivot, Xavier ;
Iwata, Hiroji ;
Aogi, Kenjiro ;
Lugo-Quintana, Roberto ;
Harbeck, Nadia ;
Brickman, Marla J. ;
Zhang, Ke ;
Kern, Kenneth A. ;
Martin, Miguel .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (01) :121-131
[5]   Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer [J].
Bear, Harry D. ;
Tang, Gong ;
Rastogi, Priya ;
Geyer, Charles E., Jr. ;
Robidoux, Andre ;
Atkins, James N. ;
Baez-Diaz, Luis ;
Brufsky, Adam M. ;
Mehta, Rita S. ;
Fehrenbacher, Louis ;
Young, James A. ;
Senecal, Francis M. ;
Gaur, Rakesh ;
Margolese, Richard G. ;
Adams, Paul T. ;
Gross, Howard M. ;
Costantino, Joseph P. ;
Swain, Sandra M. ;
Mamounas, Eleftherios P. ;
Wolmark, Norman .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04) :310-320
[6]   First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study [J].
Bergh, Jonas ;
Bondarenko, Igor M. ;
Lichinitser, Mikhail R. ;
Liljegren, Annelie ;
Greil, Richard ;
Voytko, Nataliya L. ;
Makhson, Anatoly N. ;
Cortes, Javier ;
Lortholary, Alain ;
Bischoff, Joachim ;
Chan, Arlene ;
Delaloge, Suzette ;
Huang, Xin ;
Kern, Kenneth A. ;
Giorgetti, Carla .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (09) :921-929
[7]   Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane [J].
Burstein, Harold J. ;
Elias, Anthony D. ;
Rugo, Hope S. ;
Cobleigh, Melody A. ;
Wolff, Antonio C. ;
Eisenberg, Peter D. ;
Lehman, Mary ;
Adams, Bonne J. ;
Bello, Carlo L. ;
DePrimo, Samuel E. ;
Baum, Charles M. ;
Miller, Kathy D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) :1810-1816
[8]  
Crown J, 2010, J CLIN ONCOL S18, V28, p949S
[9]  
Curigliano G, 2010, CANCER RES, V70, p451s
[10]   Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis [J].
Ebos, John M. L. ;
Lee, Christina R. ;
Cruz-Munoz, William ;
Bjarnason, Georg A. ;
Christensen, James G. ;
Kerbel, Robert S. .
CANCER CELL, 2009, 15 (03) :232-239